| Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132) |
|---|
| 04/05/2007 | US20070078129 Heterocyclic amide derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes |
| 04/05/2007 | CA2628322A1 Aldimines comprising reactive groups containing active hydrogen, and use thereof |
| 04/05/2007 | CA2623350A1 Process for the stereoselective preparation of (-)-halofenate and intermediates thereof |
| 04/05/2007 | CA2621310A1 Sulfonamide derivative having pgd2 receptor antagonistic activity |
| 04/05/2007 | CA2620878A1 Theramutein modulators |
| 04/04/2007 | EP1556387B1 Substituted benzol e| 1,4| oxazino 3,2-g| isoindole derivatives, method for preparing same and pharmaceutical compositions containing same |
| 04/04/2007 | CN1942441A Sulfonyloxy derivatives |
| 04/04/2007 | CN1942436A Lysine based compounds |
| 04/04/2007 | CN1308332C Method for preparation of aryl ethers |
| 04/03/2007 | US7199265 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 03/29/2007 | US20070073086 Process for manufacturing diphenylamines |
| 03/29/2007 | US20070072256 Optical molecular sensors for cytochrome p450 activity |
| 03/28/2007 | EP1767217A1 Agent for promoting the recovery from dysfunction after the onset of central neurological disease |
| 03/28/2007 | EP1765794A1 Phenyl substituted [1.2]-oxazine-3,5-dione and dihydropyrone derivatives |
| 03/28/2007 | EP1765325A2 2-substituted heteroaryl compounds |
| 03/28/2007 | EP0927163B1 Preparation of 1-butyl-4-piperidinylmethylamine |
| 03/27/2007 | US7196108 Bicyclic heterocycles for the treatment of diabetes and other diseases |
| 03/27/2007 | US7196087 useful for modulating the 5-HT6 receptor, the 5-HT2A receptor, or both; useful in the treatment of certain CNS disorders such as Parkinson's disease, Huntington's disease, anxiety, depression, manic depression, psychoses, epilepsy, obsessive compulsive disorders, mood disorders, migraine, Alzheimer's |
| 03/27/2007 | US7196081 Compounds with hydroxycarbonyl-halogenoalkyl side chains |
| 03/27/2007 | US7195751 For the determination of an analyte or analytes such as proteins, peptides, nucleic acids, carbohydrates, lipids, steroids and small molecules by mass analysis |
| 03/27/2007 | CA2378002C Method for preparing 2-(2-arylmorpholin-2-yl)ethanol derivatives and intermediates |
| 03/22/2007 | WO2007031698A1 Asymmetric synthesis of peptides |
| 03/22/2007 | WO2007005785B1 Thiazoles derivatives as ampk activator |
| 03/22/2007 | WO2006133339A3 Monoamine re-uptake inhibitors and methods relating thereto |
| 03/22/2007 | WO2006105127A3 Hydroxysteroid dehydrogenase inhibitors |
| 03/22/2007 | US20070066611 Reacting 4-(4-nitrophenyl)-3-morpholinone with hydrogen in the presence of a hydrogenation catalyst, characterized in that reaction is effected in an aliphatic alcohol; precursor in synthesis of 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide |
| 03/22/2007 | US20070066609 Long acting beta-2-agonists and their use as medicaments |
| 03/22/2007 | US20070066607 5-[R-2-(1S,2S-2-Cyclohexylcyclopentylamino)-1-hydroxyethyl]-8-hydroxy-1H-quinolin-2-one, useful for treating conditions that are prevented or alleviated by activation of the adrenergic recptors |
| 03/22/2007 | US20070066585 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
| 03/22/2007 | CA2622173A1 Asymmetric synthesis of peptides |
| 03/21/2007 | EP1764358A2 Cyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropathic pain |
| 03/21/2007 | CN1305914C Method for crosslinking hydrogels with morpholine-2,3-diones |
| 03/21/2007 | CN1305861C Photochromic oxazine compounds and methods for their manufacture |
| 03/20/2007 | US7192471 producing fluorescence when excited by ultraviolet light; Especially for security applications |
| 03/15/2007 | WO2006136461A3 Non-steroidal progesterone receptor modulators |
| 03/15/2007 | US20070060585 2-[1-Phenyl-2-(2-trifluoromethyl-phenyl)-ethyl]-morpholine-4-carboxylic acid benzyl ester, for example; for the treatment of disturbances of vegetative function associated with affective, anxiety and cognitive disorders |
| 03/14/2007 | EP1761509A2 Substituted cycloalkyl derivatives for the treatment of respiratory diseases |
| 03/14/2007 | EP1216031B1 Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing |
| 03/14/2007 | CN1930138A Substituted morpholine and thiomorpholine derivatives |
| 03/14/2007 | CN1304383C Benzothiazole derivatives |
| 03/14/2007 | CN1304382C New p2X* receptor antagonists for use in the treatment of inflammatory immune or cardiovascular diseases |
| 03/13/2007 | US7189847 Levofloxicin prepared by reduction of an entantiomorph of 2,3,4 trihalo,N-(1-alkoxycarbonylethyl-)aniline by a metal borohydride in an aprotic solvent and alcohol; reacting the product with a 2,2-dialkoxycarbonyl-ethyl halide; cyclization using a base and phase transfer agents; optical purity;efficiency |
| 03/13/2007 | US7189758 2-Benzyl-2-hydroxy-4-methyl-4-phenylpentanoic acid (1-oxo-1,3-dihydroisobenzofuran-5-yl)amide for example; treating type II diabetes, obesity, hypertension, arteriosclerosis, or glaucoma |
| 03/13/2007 | US7189749 Substituted phenoxyacetic acids |
| 03/13/2007 | US7189714 Administering quinoline derivative as analgesic |
| 03/13/2007 | US7189713 Piperidine derivatives |
| 03/13/2007 | US7189483 Phenothiazine, phenoxazine, or phenazine derivatives; organophotoreceptor comprising electricoconductive substrate and photoconductive element; mechanical, electrostatic, and solubility properties; used with toners for quality images |
| 03/08/2007 | WO2007026753A1 Method for producing 2-oxazoline analogue or 1,3-oxazine analogue |
| 03/08/2007 | WO2007025709A2 Organic compounds |
| 03/08/2007 | WO2006004880A3 Substituted n-arylsulfonylheterocyclic amines as gamma-secretase inhibitors |
| 03/08/2007 | CA2620222A1 Organic compounds |
| 03/08/2007 | CA2618970A1 Lisofylline analogs and methods for use |
| 03/07/2007 | EP1760073A1 Sulfonamide compound |
| 03/07/2007 | EP1759701A2 Buproprion Metabolites and Methods of Their Synthesis and Use. |
| 03/07/2007 | CN1926148A Beta-aminoacid-derivatives as factor Xa inhibitors |
| 03/07/2007 | CN1923822A Preparation method of N-isotridecyl-2,6-dimethyl morpholine |
| 03/06/2007 | US7186844 Alkyl- or phenyl-substituted 2-oxazolidinones; reacting a dihalo compound with a primary amine and carbon dioxide; nontoxic; industrial scale |
| 03/06/2007 | US7186829 Aryl-substituted heterocyclic enaminones |
| 03/06/2007 | US7186414 Improved bioavailability; for oral and intracolonic administration |
| 03/01/2007 | WO2007023056A1 Process for preparing enantiomerically enriched beta-amino acid derivatives |
| 03/01/2007 | US20070049583 Benzoxazine and benzothiazine derivatives and their use in pharmaceutical agents |
| 02/28/2007 | EP1756073A1 New isobenzoxazinones and their use as ultraviolet light absorbers |
| 02/28/2007 | EP1756072A2 Purification of progesterone receptor modulators |
| 02/28/2007 | EP1756044A1 Therapeutic compounds |
| 02/28/2007 | EP1265606B9 Cell adhesion inhibitors |
| 02/28/2007 | CN1301974C Muller Klaus-helmut |
| 02/28/2007 | CN1301966C 2-amino-2-alkyl-5-heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/28/2007 | CN1301964C Inhibitors of alpha 4 mediated cell adhesion |
| 02/27/2007 | US7183445 4-(4-Hydroxy-phenyl)-[4-(2-morpholin-4-yl-ethoxy)-benzyl]-methyl-cyclohex-3-enecarboxylic acid ethyl ester; estrogen receptor modulators for hot flashes, vaginal dryness, osteopenia, osteoporosis, hyperlipidemia, loss of cognitive function, degenerative brain diseases |
| 02/27/2007 | US7183360 Method for crosslinking hydrogels with morpholine-2,3-diones |
| 02/27/2007 | US7183279 Synergistic combinations with morphine; analgesics and cyclooxygenase-2 inhibitors, such as N-5-guanidinopentanamide-(2S)-yl-2-N-(p-hydroxyphenylacetyl)phenylenediamine and N-5-guanidinopentanamide-(2R)-yl-2-N-(p-hydroxybenzyl)-5-carboxybenzimidazole |
| 02/27/2007 | US7183277 Alpha-((aryl or heteroaryl)ureido or carbamoyloxy)-N-heteroaryl amides; blood-coagulation factor Xa and VIIa inhibitors; synergistic mixtures with other antitumor agents or anticoagulants |
| 02/27/2007 | US7183238 microbicides, pesticides and herbicides |
| 02/22/2007 | WO2007020954A1 Polymer compound and polymer light-emitting device using same |
| 02/22/2007 | WO2007020227A1 Method for producing betamimetics |
| 02/22/2007 | US20070043039 Tumor suppression agents with reduced side effects; anticancer; antibacterial and antiviral |
| 02/22/2007 | US20070043035 Novel compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them |
| 02/22/2007 | CA2619402A1 Method for producing betamimetics |
| 02/21/2007 | EP1754703A2 N-Heterocyclic derivatives as nos inhibitors |
| 02/21/2007 | EP1754701A1 Sulfonyloxy derivatives |
| 02/21/2007 | EP1753763A2 Indazole and indolone derivatives and their use as pharmaceuticals |
| 02/21/2007 | CN1917921A Calcitonin gene related peptide receptor antagonists |
| 02/21/2007 | CN1915981A 2-oxy-benzoxazinone derivatives for the treatment of obesity |
| 02/21/2007 | CN1915231A Use of nonsteroidal in preparing drug of antiinflammatory agents |
| 02/20/2007 | US7179912 Materials and methods to potentiate cancer treatment |
| 02/20/2007 | US7179839 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction |
| 02/20/2007 | US7179794 Antibiotics; bactericides |
| 02/15/2007 | WO2007018168A1 Acylguanidine derivative or salt thereof |
| 02/15/2007 | WO2007017507A1 Beta-secretase inhibitors for use in the treatment of alzheimer's disease |
| 02/15/2007 | CA2618013A1 Beta-secretase inhibitors for use in the treatment of alzheimer's disease |
| 02/15/2007 | CA2617473A1 Acylguanidine derivative or salt thereof |
| 02/14/2007 | CN1914184A Urea derivatives |
| 02/14/2007 | CN1300146C Photochromic compound of spiro [indolerin-phenanthroline oxazine and its preparation and use |
| 02/14/2007 | CN1300145C Indole oxazine compound and its synthesis and use |
| 02/13/2007 | US7176330 Fluorescent group-containing carbodiimide compound precursor, fluorescent group-containing carbodiimide compound and methods for producing them |
| 02/13/2007 | US7176242 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 02/13/2007 | US7176201 Modulation of anxiety through blockade of anandamide hydrolysis |
| 02/08/2007 | WO2007014462A1 Ep4 receptor agonist, compositions and methods thereof |
| 02/08/2007 | DE102005035527A1 Verwendung von Tetrahydrobenzoxazinen als Stabilisatoren Use of tetrahydrobenzoxazines as stabilizers |
| 02/08/2007 | CA2616608A1 Ep4 receptor agonist, compositions and methods thereof |